|
|
|
Volumn 28, Issue 2, 1996, Pages 728-
|
|
Use of a novel CD11b/CD18 inhibitory agent in a C6-deficient rat to evaluate delayed xenograft rejection
a
a
Box 1 UMHC
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD11B ANTIGEN;
CD18 ANTIGEN;
COMPLEMENT COMPONENT C3;
GLYCOPROTEIN;
NEUTROPHIL INHIBITORY FACTOR;
ANIMAL MODEL;
COMPLEMENT ACTIVATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
GRAFT REJECTION;
GRAFT SURVIVAL;
GUINEA PIG;
HEART TRANSPLANTATION;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOCYTE ACTIVATION;
LIGAND BINDING;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
RAT;
XENOTRANSPLANTATION;
ANIMALS;
ANTIGENS, CD18;
COMPLEMENT C6;
GLYCOPROTEINS;
GRAFT REJECTION;
GRAFT SURVIVAL;
GUINEA PIGS;
HEART TRANSPLANTATION;
HELMINTH PROTEINS;
IMMUNOSUPPRESSIVE AGENTS;
MACROPHAGE-1 ANTIGEN;
MEMBRANE PROTEINS;
RATS;
RATS, MUTANT STRAINS;
TRANSPLANTATION, HETEROLOGOUS;
|
|
EID: 0029969558
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
